A 27-year-old woman whose symptoms were initially thought to be endometriosis was diagnosed with stage 4 cholangiocarcinoma, also known as bile duct cancer.
Tamara Mulley, now 29, was referred to a gynaecologist in February 2023 as doctors thought her bloating and hip pain had “something like endometriosis”.
After a 10-month wait for an appointment, Tamara started experiencing a “really bad cough”, fatigue, and weight loss, and was diagnosed with cancer a month later.
She was told that she had “two years to live” in January 2024, but beat that “milestone” last month, which has motivated her to share her story.
Tamara said she first experienced bloating when she was 16, which she told doctors about numerous times over the years. When she suddenly started experiencing hip pain and fatigue in January 2023, Tamara said she initially thought she had “niggled” herself in the gym.
By February, Tamara said she went to her doctor because the hip pain was not getting any better.
This is how she said she came to start physiotherapy and get a gynaecology referral, but was not told how long the wait might be for the latter.
Over the next few months, Tamara said she chased the appointment “a couple of times” while her hip pain worsened to the point she needed to go to an emergency GP in October to get pain relief.
“It wasn’t until December of 2023 that I got a really bad cough and the symptoms from that really floored me, more than I’d ever been impacted by a cough before. Normally, you can get on with your life, but I was feeling really fatigued,” Tamara said.
“I couldn’t stand up for a long period of time at work and if I was going to someone else’s desk, I would have to sit down. And I just thought, ‘this isn’t normal’.”
Tamara said her GP did not have any available appointments, but when she mentioned she was feeling “breathless”, they encouraged her to go to A&E.
During this visit on a Friday night, Tamara said doctors did an X-ray that revealed a “little shadow”, and they encouraged her to come back on Monday to investigate it with a CT scan.
“It was at that appointment that I started to think that this could be something like cancer,” Tamara said, but doctors still were not completely sure.
She said her suspicions heightened when she got a phone call a few days later telling her to go into The Cancer Centre at Guy’s Hospital in London for a PET scan, but urging her not to worry, as it did not automatically mean she had cancer.
It was around this time that Tamara said she was finally due to have her gynaecology hospital appointment – 10 months after first requesting it – but she ultimately decided to stick with her ongoing medical investigations.
Finally, on December 23, Tamara said she got her stage 4 cancer diagnosis: “[The scans] showed that the cancer had already spread to my hip, my spine, my collarbone, multiple tumours in my lungs and quite a large tumour in my liver, among other places.”
“When I saw [the scans], it lit up like a Christmas tree. It was just kind of everywhere,” she said.
Tamara said doctors did not know where her cancer originated from, so they could not come up with a treatment plan until she had a lung biopsy on December 27, and she got the results in the third week of January 2024.
Tamara described this wait as the “hardest time” of her whole cancer journey because she felt “quite anxious” that it would grow or get worse.
During her January appointment with a consultant, Tamara said she found out her cancer was called cholangiocarcinoma (originating from her bile duct), it was “incurable”, and she was told, “you’ll be lucky if you’re sitting here in two years”.
According to the NHS, the main symptoms of cholangiocarcinoma are jaundice, itchy skin, darker pee and paler poo than usual, loss of appetite, unexplained weight loss, fatigue, and a high temperature, but Tamara only had two of these – weight loss and fatigue.
Starting on immunotherapy and initially eight rounds of chemotherapy, Tamara said she responded well to the latter so it was extended to 15 rounds, which doctors told her bought her an extra six months.
She said she did not lose her hair, which she was “so thankful” for, but she needed blood transfusions due to severe fatigue.
Despite this, Tamara said she was able to continue to do things that she loved, like go to work to keep her mind occupied or out to dinner with friends.
After chemotherapy stopped working for Tamara, she said she is “lucky enough” to currently be on a clinical trial called First-308, which is targeted therapy that she said “actually started to shrink” some of her tumours.
Out-living predictions about her health, Tamara said: “Passing that two-year mark was a real moment for me and one that I’m really proud of achieving. It goes to show that, although there’s still a huge amount of work to be done with cholangiocarcinoma – because it’s under-researched and underfunded – there is hope. My ultimate hope is for a cure to be found.
“I like to say that, within my bubble of unluckiness, I am the luckiest person in the world. I’m so thankful for the amazing medical teams who’ve been in charge of my care and that I have outlived that initial expectation. My focus now is just to continue with that.
“I always say to my doctor, you only need to keep me alive long enough for the next drug to come out, for the next discovery to be made. And hopefully, if you do that enough times, at some point they’re going to find a cure. I’m realistic about my situation, but I choose to remain positive.”
Tamara is supported by AMMF, which is the UK’s only registered charity dedicated to raising funds for research into cholangiocarcinoma.
She attended the charity’s annual conference last year, where she shared her diagnosis and treatment story, and she will be travelling to the House of Commons with AMMF to meet MPs and NHS leaders at a Rethink Liver Cancer meeting on February 25.
“Too many people with cholangiocarcinoma are diagnosed (when) it’s already stage four, and at that point it is too late,” Tamara said.
“However, if it is found at stage one or stage two, it is survivable.”
According to data published by NHS England’s National Disease Registration Service, two-thirds of patients with cholangiocarcinoma in England do not receive any cancer treatment.
Tamara added: “I’m really passionate that anyone who gets diagnosed with this in the future is not essentially handed a death sentence, and that they are given an opportunity to access the right treatment at the right time, to give them the best possible outlook.”
For more information about AMMF, visit their website here.
